SPRYCEL® (dasatinib)
Description
pulled from site's meta descriptionSPRYCEL® (dasatinib) is a prescription medicine used to treat adults who have newly diagnosed Ph+ CML in chronic phase. The effectiveness of SPRYCEL in these patients is based on certain response rates from a 1-year study that is ongoing to look at results over a longer period of time. SPRYCEL is also approved for Ph+ CML adult patients who are no longer benefitting from, or did not tolerate, other treatment including Gleevec® (imatinib mesylate).
This is an automatically generated AboutUs page for Bms354825.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
